Phase-I study of intravenous modified lipid A

Cancer Immunology Immunotherapy

Volumn 18, Issue 2, 1984, Pages 107-112

  Vosika, Gerald J ^a,b   Barr, Charles ^a,b   Gilbertson, Dennis ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; LIPID A; NEW DRUG; PETHIDINE; PHOSPHORYL LIPID A;

ADVERSE DRUG REACTION; BLOOD AND HEMOPOIETIC SYSTEM; BRONCHOSPASM; CANCER CHEMOTHERAPY; CANCER THERAPY; CARDIOVASCULAR SYSTEM; CHILL; CLINICAL ARTICLE; DRUG EFFICACY; DRUG THERAPY; FEVER; HUMAN; HYPOTENSION; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; PHARMACOKINETICS; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RESPIRATORY SYSTEM; THERAPY; THROMBOCYTOPENIA;

ANIMAL; DRUG EVALUATION; IMMUNOTHERAPY; INJECTIONS, INTRAVENOUS; LIPID A; NEOPLASMS; SALMONELLA; SALMONELLA TYPHIMURIUM; SKIN TESTS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0021750647     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/BF00205743     Document Type: Article

References (27)

1. A report of recent cases of inoperable sarcoma treated with mixed toxins of Erysipelas and Bacillus prodigious
2. Reaction of spontaneous mouse carcinomas to blood-carried bacterial toxins
3. Eradication of spontaneous metastasis and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide
4. Detoxification of bacterial endotoxin with retention of ability to stimulate non-specific resistance to infection
5. Le phénomène de Schwartzman dans le sarcome du cobaye
6. Heterogeneity within the population of NK and K cells
7. Immunobiological activities of synthetic lipid A analogs and related compounds as compared to those of bacterial lipopolysaccharide, re-glycolipid, lipid A and muramyl dipeptide
8. Lipid A: Chemical structure and biological Activity
9. Characterization of two membrane-associated glycolipids from an Escherichia coli mutant deficient in phosphatidylglycerol
10. The tumor nectrotizing effect of Lipid A component of Escherichia coli endotoxin
11. End results in reticulum cell sarcoma of bone treated by bacterial toxin therapy alone or combined with surgery and/or radiotherapy (47 cases) or concurrent infection (5 cases)
12. Bacterial endotoxins as an immunotherapeutic agent — Basic data on mechanisms of action
13. Fate and effect of endotoxin derivatives in tumor-bearing mice
14. Demonstration of non-specific suppressor cells in peripheral lymphocytes of cancer patients
15. The effects of experimental conditions on the expression of in vitro-mediated tumor cytotoxicity mediated by murine macrophages
16. Immunotherapy and antitumor activity of non-toxic Lipid A
17. Lipid A mutants of Salmonella typhimurium
18. Chemical treatment of tumors; reactions of mice with primary subcutaneous tumors to injections of hemorrhage-producing bacterial polysaccharide
19. Chemical treatment of tumors; isolations of hemorrhagic-producing fraction from Serratia marcescens Bacillus prodigiosus culture filtrate
20. Direct activation of tumorcidal properties in rat alveolar macrophages by Nocardia rubra cell wall skeleton
21. Isolation of non-toxic Lipid A fraction containing tumor regression activity
22. Phase I–II study of intralesional immunotherapy with oil-attached Mycobacterium smegmatis cell wall skeleton and trehalose dimycolate
23. Intralesional immunotherapy of malignant melanoma with mycobacterium smegmatis cell wall skeleton combined with trehalose dimycolate
24. Effect of indomethacin on blastogensis of lymphocytes from cancer patients: Differentiation of patient types
25. History of pyrogenic research